323 related articles for article (PubMed ID: 34739585)
21. Expression of Yes-associated protein in cervical squamous epithelium lesions.
Xiao H; Wu L; Zheng H; Li N; Wan H; Liang G; Zhao Y; Liang J
Int J Gynecol Cancer; 2014 Nov; 24(9):1575-82. PubMed ID: 25304677
[TBL] [Abstract][Full Text] [Related]
22. Cox-2, EGFR, and ERBB-2 expression in cervical intraepithelial neoplasia and cervical cancer using an automated imaging system.
Fukazawa EM; Baiocchi G; Soares FA; Kumagai LY; Faloppa CC; Badiglian-Filho L; Coelho FR; Gonçalves WJ; Costa RL; Góes JC
Int J Gynecol Pathol; 2014 May; 33(3):225-34. PubMed ID: 24681731
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
24. Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation.
Vogelsang TLR; Schmoeckel E; Kuhn C; Blankenstein T; Temelkov M; Heidegger H; Kolben TM; Kolben T; Mahner S; Mayr D; Jeschke U; Vattai A
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1847-1855. PubMed ID: 32157438
[TBL] [Abstract][Full Text] [Related]
25. Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia.
Lee YY; Song SY; Do IG; Kim TJ; Kim BG; Lee JW; Bae DS
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):180-4. PubMed ID: 22959143
[TBL] [Abstract][Full Text] [Related]
26. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3.
Ovestad IT; Gudlaugsson E; Skaland I; Malpica A; Munk AC; Janssen EA; Baak JP
J Clin Pathol; 2011 Apr; 64(4):303-7. PubMed ID: 21421698
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
Am J Clin Pathol; 2009 Dec; 132(6):883-92. PubMed ID: 19926580
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
29. Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions.
Barbosa LC; da Silva ID; Corrêa JC; Ribalta JC
Int J Gynecol Cancer; 2011 Jan; 21(1):15-21. PubMed ID: 21330827
[TBL] [Abstract][Full Text] [Related]
30. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
31. Aberrant Expression of the Cell Polarity Regulator aPKCλ/ι is Associated With Disease Progression in Cervical Intraepithelial Neoplasia (CIN): A Possible Marker for Predicting CIN Prognosis.
Mizushima T; Asai-Sato M; Akimoto K; Nagashima Y; Taguri M; Sasaki K; Nakaya MA; Asano R; Tokinaga A; Kiyono T; Hirahara F; Ohno S; Miyagi E
Int J Gynecol Pathol; 2016 Mar; 35(2):106-17. PubMed ID: 26535980
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of T, B and natural killer lymphocyte in the cervical stroma of HIV-positive and negative patients with cervical intraepithelial neoplasia.
Lucena AA; Guimarães MV; Michelin MA; Lodi CT; Lima MI; Murta EF; Melo VH
Immunol Lett; 2016 Jan; 169():98-103. PubMed ID: 26545568
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Longatto-Filho A; Syrjänen K
Am J Clin Pathol; 2010 Jul; 134(1):50-9. PubMed ID: 20551266
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome.
Lindström AK; Hellberg D
Eur J Histochem; 2014 Apr; 58(2):2227. PubMed ID: 24998916
[TBL] [Abstract][Full Text] [Related]
35. Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia.
Visser J; Nijman HW; Hoogenboom BN; Jager P; van Baarle D; Schuuring E; Abdulahad W; Miedema F; van der Zee AG; Daemen T
Clin Exp Immunol; 2007 Nov; 150(2):199-209. PubMed ID: 17937675
[TBL] [Abstract][Full Text] [Related]
36. Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Int J Gynecol Pathol; 2008 Apr; 27(2):265-73. PubMed ID: 18317213
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K;
Diagn Cytopathol; 2006 Aug; 34(8):555-63. PubMed ID: 16850495
[TBL] [Abstract][Full Text] [Related]
38. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
[TBL] [Abstract][Full Text] [Related]
39. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer.
Lu D; Yang X; Jiang NY; Woda BA; Liu Q; Dresser K; Mercurio AM; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Nov; 35(11):1638-45. PubMed ID: 21997684
[TBL] [Abstract][Full Text] [Related]
40. [Association of p16, p53, Ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].
Shi J; Zheng JS; Yin F; Hu WW; Huang XJ; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):515-7. PubMed ID: 17545048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
